Literature DB >> 14991547

Acinar cell carcinoma arising in the stomach: a case report with literature review.

Yanyu Sun1, Patricia G Wasserman.   

Abstract

Acinar cell carcinomas (ACCs) are uncommon malignant tumors of the exocrine pancreas, constituting 1% to 2% of all nonendocrine pancreatic neoplasms. Cases of acinar cell carcinoma developing in heterotopic pancreatic tissue are extremely rare. To the best of our knowledge, no cases of primary ACC developing in the stomach have been reported in the literature. We report the first case of a primary ACC arising in the stomach in an 86-year-old female who presented with a 5-cm gastric submucosal mass with superficial ulceration and a history of anemia. The neoplasm exhibited typical acinar morphology. Immunohistochemical studies demonstrated strong positive reactivity for antitrypsin and antichymotrypsin, and electron microscopy confirmed the presence of zymogen granules. A complete metastatic workup failed to identify any primary pancreatic tumor or other nonpancreatic tumor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991547     DOI: 10.1016/j.humpath.2003.09.020

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  23 in total

Review 1.  Synchronous occurrence of carcinoid, signet-ring cell carcinoma and heterotopic pancreatic tissue in stomach: A case report and literature review.

Authors:  Lin Yang; Hong-Tu Zhang; Xun Zhang; Yun-Tian Sun; Zhi Cao; Qin Su
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

Review 2.  Therapeutic procedures for submucosal tumors in the gastrointestinal tract.

Authors:  Laura-Graves Ponsaing; Mark-Berner Hansen
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

3.  Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy.

Authors:  Emmet J Jordan; Olca Basturk; Jinru Shia; David S Klimstra; William Alago; Michael I D'Angelica; Ghassan K Abou-Alfa; Eileen M O'Reilly; Maeve A Lowery
Journal:  J Gastrointest Oncol       Date:  2017-10

Review 4.  Malignant Transformation of Ectopic Pancreas.

Authors:  Irina M Cazacu; Adriana Alexandra Luzuriaga Chavez; Graciela M Nogueras Gonzalez; Adrian Saftoiu; Manoop S Bhutani
Journal:  Dig Dis Sci       Date:  2018-11-10       Impact factor: 3.199

5.  Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy.

Authors:  Maeve A Lowery; David S Klimstra; Jinru Shia; Kenneth H Yu; Peter J Allen; Murray F Brennan; Eileen M O'Reilly
Journal:  Oncologist       Date:  2011-10-31

6.  Colonic carcinoma with a pancreatic acinar cell differentiation. A case report.

Authors:  Anna Maria Chiaravalli; Giovanna Finzi; Valentina Bertolini; Stefano La Rosa; Carlo Capella
Journal:  Virchows Arch       Date:  2009-11-12       Impact factor: 4.064

7.  Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature.

Authors:  Akhil K Seth; Pedram Argani; Kurtis A Campbell; John L Cameron; Timothy M Pawlik; Richard D Schulick; Michael A Choti; Christopher L Wolfgang
Journal:  J Gastrointest Surg       Date:  2007-10-24       Impact factor: 3.452

8.  Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case.

Authors:  Kimihide Kusafuka; Etsuro Bando; Koji Muramatsu; Hiroaki Ito; Yutaka Tanizawa; Taiichi Kawamura; Toru Mochizuki; Masanori Terashima; Takashi Nakajima
Journal:  Med Mol Morphol       Date:  2009-09-26       Impact factor: 2.309

9.  Severe panniculitis and polyarthritis caused by acinar cell carcinoma arising from an ectopic pancreas.

Authors:  Marc Plier; Patrick Durez; Mina Komuta; Alexandros Raptis
Journal:  BMJ Case Rep       Date:  2017-11-21

10.  Classification of submucosal tumors in the gastrointestinal tract.

Authors:  Laura-Graves Ponsaing; Katalin Kiss; Mark-Berner Hansen
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.